In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series B results in $17.5mm for ArKal Medical

Executive Summary

ArKal Medical (glucose monitoring) brought in $17.5mm through its Series B financing round led by Thomas McNerney & Partners, with additional participation from returning shareholders Delphi Ventures and MedVenture Associates.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register